Profile | GDS5420 / 216071_x_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 1100.17 | 80 |
GSM1296119 | B_lesional_pre-dose | 707.1 | 74 |
GSM1296076 | C_lesional_pre-dose | 342.18 | 63 |
GSM1296092 | D_lesional_pre-dose | 675.94 | 73 |
GSM1296103 | E_lesional_pre-dose | 1079.84 | 80 |
GSM1296078 | F_lesional_pre-dose | 395.92 | 65 |
GSM1296107 | G_lesional_pre-dose | 690.76 | 73 |
GSM1296109 | H_lesional_pre-dose | 811.84 | 76 |
GSM1296080 | I_lesional_pre-dose | 1148.37 | 81 |
GSM1296090 | J_lesional_pre-dose | 564.82 | 70 |
GSM1296074 | K_lesional_pre-dose | 483.96 | 68 |
GSM1296111 | L_lesional_pre-dose | 649.16 | 72 |
GSM1296099 | M_lesional_pre-dose | 861.09 | 77 |
GSM1296086 | O_lesional_pre-dose | 583.12 | 71 |
GSM1296117 | P_lesional_pre-dose | 693.94 | 73 |
GSM1296113 | Q_lesional_pre-dose | 878.44 | 77 |
GSM1296096 | R_lesional_pre-dose | 715.49 | 74 |
GSM1296105 | S_lesional_pre-dose | 1021.27 | 79 |
GSM1296098 | T_lesional_pre-dose | 1228.46 | 82 |
GSM1296101 | U_lesional_pre-dose | 1092.5 | 81 |
GSM1296121 | V_lesional_pre-dose | 875.81 | 77 |
GSM1296088 | W_lesional_pre-dose | 775.52 | 75 |
GSM1296082 | X_lesional_pre-dose | 429.28 | 66 |
GSM1296115 | Y_lesional_pre-dose | 629.46 | 72 |
GSM1296084 | Z_lesional_pre-dose | 846.11 | 76 |
GSM1296072 | B_lesional_day8 | 851.77 | 77 |
GSM1296069 | L_lesional_day8 | 694.9 | 73 |
GSM1296071 | P_lesional_day8 | 924.18 | 78 |
GSM1296070 | Y_lesional_day8 | 695.61 | 73 |
GSM1296073 | V_lesional_day8 | 724.62 | 74 |
GSM1296034 | A_lesional_day15 | 1562.39 | 86 |
GSM1296041 | G_lesional_day15 | 533.73 | 69 |
GSM1296035 | R_lesional_day15 | 979.15 | 79 |
GSM1296038 | U_lesional_day15 | 810.45 | 76 |
GSM1296047 | B_lesional_day15 | 846.27 | 77 |
GSM1296039 | E_lesional_day15 | 660.65 | 73 |
GSM1296042 | H_lesional_day15 | 687.84 | 73 |
GSM1296043 | L_lesional_day15 | 711.86 | 74 |
GSM1296037 | M_lesional_day15 | 1232.96 | 83 |
GSM1296046 | P_lesional_day15 | 737.47 | 74 |
GSM1296044 | Q_lesional_day15 | 830.28 | 76 |
GSM1296045 | Y_lesional_day15 | 714.83 | 74 |
GSM1296025 | C_lesional_day15 | 1107.08 | 80 |
GSM1296033 | D_lesional_day15 | 873.24 | 77 |
GSM1296027 | I_lesional_day15 | 1101.13 | 80 |
GSM1296032 | J_lesional_day15 | 994.12 | 79 |
GSM1296024 | K_lesional_day15 | 1144.71 | 81 |
GSM1296031 | W_lesional_day15 | 846.64 | 76 |
GSM1296028 | X_lesional_day15 | 962.53 | 78 |
GSM1296029 | Z_lesional_day15 | 1201.79 | 82 |
GSM1296026 | F_lesional_day15 | 694.66 | 73 |
GSM1296030 | O_lesional_day15 | 1022.25 | 79 |
GSM1296040 | S_lesional_day15 | 984.97 | 79 |
GSM1296036 | T_lesional_day15 | 1076.78 | 80 |
GSM1296048 | V_lesional_day15 | 785.07 | 75 |
GSM1296059 | A_lesional_day43 | 883.08 | 77 |
GSM1296066 | G_lesional_day43 | 682.32 | 73 |
GSM1296060 | R_lesional_day43 | 801.15 | 75 |
GSM1296063 | U_lesional_day43 | 651.71 | 72 |
GSM1296064 | E_lesional_day43 | 668.84 | 73 |
GSM1296067 | H_lesional_day43 | 1029.44 | 80 |
GSM1296062 | M_lesional_day43 | 1254.88 | 83 |
GSM1296068 | Q_lesional_day43 | 872.72 | 77 |
GSM1296050 | C_lesional_day43 | 600.36 | 71 |
GSM1296057 | D_lesional_day43 | 1287.36 | 83 |
GSM1296052 | I_lesional_day43 | 1160 | 81 |
GSM1296054 | J_lesional_day43 | 1265.03 | 83 |
GSM1296049 | K_lesional_day43 | 1039.89 | 80 |
GSM1296055 | W_lesional_day43 | 994.46 | 79 |
GSM1296053 | X_lesional_day43 | 1137.06 | 81 |
GSM1296058 | Z_lesional_day43 | 1150.01 | 81 |
GSM1296051 | F_lesional_day43 | 507.64 | 69 |
GSM1296056 | O_lesional_day43 | 858.36 | 77 |
GSM1296065 | S_lesional_day43 | 743.46 | 74 |
GSM1296061 | T_lesional_day43 | 1216.19 | 82 |
GSM1296095 | A_non-lesional_pre-dose | 867.48 | 77 |
GSM1296120 | B_non-lesional_pre-dose | 870.36 | 77 |
GSM1296077 | C_non-lesional_pre-dose | 900.54 | 77 |
GSM1296093 | D_non-lesional_pre-dose | 1221.69 | 83 |
GSM1296104 | E_non-lesional_pre-dose | 825.12 | 76 |
GSM1296079 | F_non-lesional_pre-dose | 737.03 | 74 |
GSM1296108 | G_non-lesional_pre-dose | 837 | 76 |
GSM1296110 | H_non-lesional_pre-dose | 901.38 | 78 |
GSM1296081 | I_non-lesional_pre-dose | 1926.59 | 88 |
GSM1296091 | J_non-lesional_pre-dose | 752.23 | 74 |
GSM1296075 | K_non-lesional_pre-dose | 547.43 | 70 |
GSM1296112 | L_non-lesional_pre-dose | 878.87 | 77 |
GSM1296100 | M_non-lesional_pre-dose | 1463.37 | 85 |
GSM1296087 | O_non-lesional_pre-dose | 992.41 | 79 |
GSM1296118 | P_non-lesional_pre-dose | 922.16 | 78 |
GSM1296114 | Q_non-lesional_pre-dose | 846.71 | 77 |
GSM1296097 | R_non-lesional_pre-dose | 899.3 | 77 |
GSM1296106 | S_non-lesional_pre-dose | 1023.08 | 79 |
GSM1296102 | U_non-lesional_pre-dose | 1289.87 | 83 |
GSM1296122 | V_non-lesional_pre-dose | 991.68 | 79 |
GSM1296089 | W_non-lesional_pre-dose | 959.72 | 78 |
GSM1296083 | X_non-lesional_pre-dose | 1321.81 | 83 |
GSM1296116 | Y_non-lesional_pre-dose | 824.23 | 76 |
GSM1296085 | Z_non-lesional_pre-dose | 1123.09 | 81 |